Fufat...
Agree with your comments. My takeaway from this Q1 Report.
Prod Development seems on track and consistent with targeted goals communicated earlier this year
Mfg capability and readiness shows much progress with monthly capability
Product sales are moving up over the past year but vs q4 trend is down. Not alarming as this was mentioned in Annual Report
I’m wait and see at what the Walmart deal is about. And perplexed at Kroger and CVS status is. Hopefully clarity during this quarter or as part of Q2.
I’m not an insider and have very limited knowledge of this industry. I have substantial shares purchased on open market and have been in this stock for around 4 years and call the company 2-4 times during the year. With that, few more comments...
Product offering and execution has been well thought out and was read between lines communicated over time. I rate this as most significant and credit to company
Mfg is a bit unknown but progress made esp now that it’s only contracted overseas. Seems like ducks in row here.
Sakes are sluggish at best. I don’t know why. What’s needed on Q reports is sales by product. I want to understand progress of portfolio as it relates to sales. This breakdiwn likely or should happen this year. Product line profitability will be next and should be next year.
I wonder what acctg systems are in place?
I wonder if right expertise at company on sales-marketing end? This is really next major business issue to to get lined up
I wonder about company plans as ongoing concern? Surely if the portfolio is “right” offers will abound
I wonder about lawsuit with J&J? To me it’s the dessert after dinner
I wonder why the stock price is so low? Seems artificially depressed but seems no real buyers either.
I wonder if DECN really has the goods what a fair valuation is?
I wonder if we will all be posting on this board next year with these same type questions. I think not, hope not and if wrong (how could i be so duped)?
GLTA...
Agree with your comments. My takeaway from this Q1 Report.
Prod Development seems on track and consistent with targeted goals communicated earlier this year
Mfg capability and readiness shows much progress with monthly capability
Product sales are moving up over the past year but vs q4 trend is down. Not alarming as this was mentioned in Annual Report
I’m wait and see at what the Walmart deal is about. And perplexed at Kroger and CVS status is. Hopefully clarity during this quarter or as part of Q2.
I’m not an insider and have very limited knowledge of this industry. I have substantial shares purchased on open market and have been in this stock for around 4 years and call the company 2-4 times during the year. With that, few more comments...
Product offering and execution has been well thought out and was read between lines communicated over time. I rate this as most significant and credit to company
Mfg is a bit unknown but progress made esp now that it’s only contracted overseas. Seems like ducks in row here.
Sakes are sluggish at best. I don’t know why. What’s needed on Q reports is sales by product. I want to understand progress of portfolio as it relates to sales. This breakdiwn likely or should happen this year. Product line profitability will be next and should be next year.
I wonder what acctg systems are in place?
I wonder if right expertise at company on sales-marketing end? This is really next major business issue to to get lined up
I wonder about company plans as ongoing concern? Surely if the portfolio is “right” offers will abound
I wonder about lawsuit with J&J? To me it’s the dessert after dinner
I wonder why the stock price is so low? Seems artificially depressed but seems no real buyers either.
I wonder if DECN really has the goods what a fair valuation is?
I wonder if we will all be posting on this board next year with these same type questions. I think not, hope not and if wrong (how could i be so duped)?
GLTA...
6
